MANGALAM — Mangalam Drugs and Organics Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapValue Trap

Annual income statement for Mangalam Drugs and Organics, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	3,801	4,511	3,723	3,686	3,182
Cost of Revenue
Gross Profit	1,284	1,170	915	923	1,194
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	3,360	4,123	3,577	3,658	2,987
Operating Profit	442	388	145	28.1	196
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	395	277	22.1	-111	47.9
Provision for Income Taxes
Net Income After Taxes	280	197	12.7	-90.5	67.2
Net Income Before Extraordinary Items
Net Income	280	197	12.7	-90.5	67.2
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	280	197	12.7	-90.5	67.2
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	17.7	12.4	0.804	-5.7	4.22